Szkukalek, J.; Dóczi, R.; Dirner, A.; Boldizsár, Á.; Varga, Á.; Déri, J.; Lakatos, D.; Tihanyi, D.; Vodicska, B.; Schwáb, R.;
et al. Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support. Diagnostics 2021, 11, 1850.
https://doi.org/10.3390/diagnostics11101850
AMA Style
Szkukalek J, Dóczi R, Dirner A, Boldizsár Á, Varga Á, Déri J, Lakatos D, Tihanyi D, Vodicska B, Schwáb R,
et al. Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support. Diagnostics. 2021; 11(10):1850.
https://doi.org/10.3390/diagnostics11101850
Chicago/Turabian Style
Szkukalek, Judita, Róbert Dóczi, Anna Dirner, Ákos Boldizsár, Ágnes Varga, Júlia Déri, Dóra Lakatos, Dóra Tihanyi, Barbara Vodicska, Richárd Schwáb,
and et al. 2021. "Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support" Diagnostics 11, no. 10: 1850.
https://doi.org/10.3390/diagnostics11101850
APA Style
Szkukalek, J., Dóczi, R., Dirner, A., Boldizsár, Á., Varga, Á., Déri, J., Lakatos, D., Tihanyi, D., Vodicska, B., Schwáb, R., Pajkos, G., Várkondi, E., Vályi-Nagy, I., Valtinyi, D., Nagy, Z., & Peták, I.
(2021). Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support. Diagnostics, 11(10), 1850.
https://doi.org/10.3390/diagnostics11101850
